Results 221 to 230 of about 882,069 (246)
Some of the next articles are maybe not open access.
Digestion, 1985
The serum carbohydrate antigenic determinant (CA 19-9) was assayed in patients with various diseases, and it provides excellent sensitivity for adenocarcinoma of the pancreas (25/27, 93%), while only 4% (2/54) of the patients with benign diseases and none of the 40 healthy subjects showed elevated CA 19-9 concentrations over 37 units/ml as upper normal
T, Yoshikawa +4 more
openaire +2 more sources
The serum carbohydrate antigenic determinant (CA 19-9) was assayed in patients with various diseases, and it provides excellent sensitivity for adenocarcinoma of the pancreas (25/27, 93%), while only 4% (2/54) of the patients with benign diseases and none of the 40 healthy subjects showed elevated CA 19-9 concentrations over 37 units/ml as upper normal
T, Yoshikawa +4 more
openaire +2 more sources
Vorkommen der tumorassoziierten Antigene CA 50 und CA 19-9 in Endometriumkarzinomen
Archives of Gynecology and Obstetrics, 1993Das tumorassoziierte Antigen CA 19-9 entspricht dem sialysierten Lewisa Blutgrup- penantigen. Das Antigen CA 50 setzt sich aus diesem Epitop und einer weiteren Zuckergruppe zusammen. Serumbestimmungen von CA 19-9 und CA 50 eignen sich zur Verlaufskontrolle von Pankreas- und Dickdarmkarzinomen (Nakagoe et al.; Schwenk et al.).
U. -J. Göhring +3 more
openaire +1 more source
Rheumatoid factor interference in the determination of carbohydrate antigen 19-9 (CA 19-9)
Clinical Chemistry and Laboratory Medicine (CCLM), 2006AbstractClin Chem Lab Med 2006;44:1137–9.
Mario, Berth +6 more
openaire +2 more sources
The Need for Assay Harmonization: Carbohydrate Antigen 19-9 (CA 19-9) Assay Example
Turkish Society of Clinical Biochemistry, 2022Amaç: CA 19-9, yüksek riskli kişilerde pankreas, safra kanalı ve kolon kanserlerinin tespiti ve takibinde diğer testlerin tamamlayıcısı olarak yaygın kullanılan bir biyobelirteçtir. CA 19-9 testinin farklı yöntemlerle ölçüm sonuçları arasında uyumsuzluklar bulunabilmektedir. Bu çalışmanın amacı CA 19-9 testinin harmonizasyon problemini ortaya koymaktır.
Fatma Uçar +3 more
openaire +1 more source
1995
This tumour-associated antigen is a high molecular weight mucin epitope expression is defined by a homologous monoclonal antibody system — the CA 19-9 antibody The antigenic epitope represents a sialylated Lewisa blood group pentasaccharide and, as such, is similar to that detected by some other monocloncal antibody systems.
openaire +1 more source
This tumour-associated antigen is a high molecular weight mucin epitope expression is defined by a homologous monoclonal antibody system — the CA 19-9 antibody The antigenic epitope represents a sialylated Lewisa blood group pentasaccharide and, as such, is similar to that detected by some other monocloncal antibody systems.
openaire +1 more source
CA 19–9, GICA (Gastrointestinal Cancer Antigen)
1992Following the detection and clinical exploitation of alphafetoprotein (AFP), calcinoembryonic antigen (CEA), and human chorionic genadotropin (HCG) as first and basic tumor markers, the discovery of blood group-related carbohydrate structures on glycoproteins and glycolipids as indicators of malignancy has opened a wide array of scientific and clinical
openaire +1 more source
[Carbohydrate antigen CA 19-9: value in pancreatic pathology].
Gastroenterologie clinique et biologique, 1986In order to determine the diagnostic usefulness of the dosage of carbohydrate antigen (CA 19-9) serum levels in pancreatic diseases, 38 patients with pancreatic lesions proved at laparotomy were studied. Pancreatic lesions were classified into two groups: a) group I: pancreatic adenocarcinoma (17 cases) b) group II: benign pancreatic diseases (21 cases)
J, Venot +5 more
openaire +1 more source
Serum carbohydrate antigen (CA) 19-9 as a prognostic factor in cholangiocarcinoma: A meta-analysis
Frontiers of Medicine in China, 2010This study was performed to determine the prognostic role of preoperative serum carbohydrate antigen (CA) 19-9 levels in the survival of patients with cholangiocarcinoma. Articles published up to June 1(st), 2010 that evaluated preoperative CA19-9 levels and the prognosis of cholangiocarcinoma were collected for meta-analysis.
Shang-Long, Liu +6 more
openaire +2 more sources
Clinical value of CA 19-9 (carbohydrate antigen) in gastrointestinal adenocarcinoma.
The Italian journal of surgical sciences, 1985CA 19-9 and CEA serum levels were determined before and 7 days after surgery in 140 patients with gastrointestinal adenocarcinoma, and in 70 patients with gastrointestinal non neoplastic diseases. CA 19-9 test was shown to be positive in 37.9% of colorectal cancer, in 32.6% of gastric cancer and in 77.8% of pancreatic cancer.
MENNINI, Giuseppe +7 more
openaire +2 more sources
Serum CA 19-9 and CA 50 antigens in hemodialysis patients.
Clinical nephrology, 1987Serum concentrations of monoclonal antibody-defined tumor markers CA 19-9 and CA 50 were measured in 64 uncomplicated hemodialysis patients (Group 1) and in 8 hemodialysis patients with cancer (Group 2) in comparison with corresponding CEA determinations.
D, Docci +5 more
openaire +1 more source